Saturday, April 29, 2017 11:29:22 PM
biosynthesis ---> sounds cool, but lots of competition. There seems to be a lot of companies who can create synthetic cannibinoids (or combos). Like you said, if it really is a disruptive tech with high yield/low cost, why haven't people come knocking?
bioinformatics ---> i feel like all the big boys have similar systems, but dont bother pumping it because they have quality candidates
Drugs --> a long way away and better IP exists out there already (NMUS) and a bunch of cheap warrants flying around
I took profits when it popped, and will wait and see on IMLFF. I make my own choices, dont worry vinpat!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM